Aviva plc (LON:AV) has received an average recommendation of “Buy” from the seventeen ratings firms that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, four have given a hold recommendation and eleven have issued a buy recommendation on the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is GBX 568.58 ($7.36).
Several brokerages recently weighed in on AV. Deutsche Bank reissued a “buy” rating and issued a GBX 600 ($7.77) price objective on shares of Aviva in a report on Friday, May 25th. Goldman Sachs Group raised Aviva to a “buy” rating and lifted their price objective for the stock from GBX 525 ($6.80) to GBX 590 ($7.64) in a report on Monday, May 28th. Credit Suisse Group decreased their price objective on Aviva from GBX 640 ($8.28) to GBX 590 ($7.64) and set an “outperform” rating for the company in a report on Friday, May 4th. JPMorgan Chase & Co. reissued an “overweight” rating and issued a GBX 636 ($8.23) price objective on shares of Aviva in a report on Tuesday, May 1st. Finally, Barclays lifted their price objective on Aviva from GBX 573 ($7.42) to GBX 581 ($7.52) and gave the stock an “overweight” rating in a report on Wednesday, July 18th.
Shares of Aviva traded down GBX 5 ($0.06), hitting GBX 497.80 ($6.44), during trading hours on Thursday, MarketBeat.com reports. 14,250,033 shares of the company’s stock traded hands, compared to its average volume of 10,250,000. Aviva has a 12-month low of GBX 482.20 ($6.24) and a 12-month high of GBX 550 ($7.12).
Aviva plc provides various insurance and savings products primarily in the United Kingdom, rest of Europe, Canada, and Asia. The company offers life insurance, long term health and accident insurance, pension, and annuity products; and lifetime mortgage products. It also provides insurance cover to individuals, and small and medium-sized businesses for risks associated primarily with motor vehicles, property, and medical expenses, as well as liabilities, such as employers' and professional indemnity liabilities.
Recommended Story: Leveraged Buyout (LBO)
Receive News & Ratings for Aviva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aviva and related companies with MarketBeat.com's FREE daily email newsletter.